US Patent 11085030 MAD nucleases
Patent 11085030 was granted and assigned to Inscripta on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+137 characters)
Article
Patent abstract
The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110850300
Date of Patent
August 10, 2021
0Patent Application Number
202103120
Date Filed
March 12, 2021
0Official Website
Patent Citations Received
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110850300
Date of Patent
August 10, 2021
0Patent Application Number
202103120
Date Filed
March 12, 2021
0Official Website
Patent Citations Received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 7 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11085030 MAD nucleases
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11085030
Date of patent
August 10, 2021
Patent application number
20210312
Date Filed
March 12, 2021
Find more entities like US Patent 11085030 MAD nucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.